Skip to main content

Home/ Nutrition/ Group items tagged triglycerides

Rss Feed Group items tagged

Matti Narkia

NEJM -- Extended-Release Niacin or Ezetimibe and Carotid Intima-Media Thickness - 0 views

    Extended-release niacin or ezetimibe and carotid intima-media thickness.
    Taylor AJ, Villines TC, Stanek EJ, Devine PJ, Griffen L, Miller M, Weissman NJ, Turco M.
    N Engl J Med. 2009 Nov 26;361(22):2113-22. Epub 2009 Nov 15.
    PMID: 19915217

    Conclusions This comparative-effectiveness trial shows that the use of extended-release niacin causes a significant regression of carotid intima-media thickness when combined with a statin and that niacin is superior to ezetimibe. ( number, NCT00397657 [] .
Matti Narkia

Acute Ingestion of Long-Chain (n-3) Polyunsaturated Fatty Acids Decreases Fibrinolysis ... - 0 views

    Acute Ingestion of Long-Chain (n-3) Polyunsaturated Fatty Acids Decreases Fibrinolysis in Men with Metabolic Syndrome.
    Montegaard C, Tulk HM, Lauritzen L, Tholstrup T, Robinson LE.
    J Nutr. 2009 Nov 4. [Epub ahead of print]
    PMID: 19889809

    Individuals with metabolic syndrome (MetS) often have elevated plasma plasminogen activator inhibitor-1 (PAI-1) and tissue plasminogen activator (t-PA), contributing to an increased risk of cardiovascular disease. PAI-1 and t-PA may be affected by chronic (n-3) long-chain PUFA [(n-3)LCPUFA] supplementation; however, the acute impact of fat ingestion on these risk factors has not been established. Our objective was to investigate the acute effect of (n-3)LCPUFA on plasma PAI-1, t-PA, and platelet aggregation. We conducted a randomized crossover study in which men (n = 8, ≥45 y) with MetS consumed water or a high-saturated fat beverage (1 g fat/kg body weight) with either a high or low content of (n-3)LCPUFA. Blood samples were collected over 8 h to measure triacylglycerol (TAG), PAI-1, t-PA, and platelet aggregation. Both fat loads resulted in a significant increase in whole blood TAG concentration, plasma PAI-1 and t-PA concentrations, and PAI-1 activity, as well as a significant decrease in t-PA activity during the postprandial period. Interestingly, PAI-1 concentration and activity increased more following the high (n-3)LCPUFA compared with the low (n-3)LCPUFA beverage (P < 0.05). Furthermore, the high (n-3)LCPUFA beverage resulted in a lower t-PA activity (P < 0.05), whereas the effects of the 2 fat loads on the plasma t-PA concentration and platelet aggregation did not differ. Overall, acute intake of a high (n-3)LCPUFA beverage shifted the balance between plasma PAI-1 and t-PA, which might indicate a lower capacity for fibrinolysis
Matti Narkia

Coconut kernel protein modifies the effect of coconut oil on serum lipids. - Plant Food... - 0 views

    Coconut kernel protein modifies the effect of coconut oil on serum lipids.
    Padmakumaran Nair KG, Rajamohan T, Kurup PA.
    Plant Foods Hum Nutr. 1999;53(2):133-44.
    PMID: 10472790
    DOI: 10.1023/A:1008078103299

    Feeding coconut kernel along with coconut oil in human volunteers has been found to reduce serum total and LDL cholesterol when compared to feeding coconut oil alone. This effect of the kernel was also observed in rats. Since many plant proteins have been reported to exert a cholesterol lowering effect, a study was carried out on the effect of isolated kernel protein in rats. Feeding kernel protein resulted in lower levels of cholesterol, phospholipids and triglycerides in the serum and most tissues when compared to casein fed animals. Rats fed kernel protein had (1) increased hepatic degradation of cholesterol to bile acids, (2) increased hepatic cholesterol biosynthesis, and (3) decreased esterification of free cholesterol. In the intestine, however, cholesterogenesis was decreased. The kernel protein also caused decreased lipogenesis in the liver and intestine. This beneficial effect of the kernel protein is attributed to its very low lysine/arginine ratio 2.13% lysine and 24.5% arginine....
Matti Narkia

Beneficial effects of virgin coconut oil on lipid parameters and in vitro LDL oxidation... - 0 views

    Beneficial effects of virgin coconut oil on lipid parameters and in vitro LDL oxidation.
    Nevin KG, Rajamohan T.
    Clin Biochem. 2004 Sep;37(9):830-5.
    PMID: 15329324

    Conclusion: The results demonstrated the potential beneficiary effect of virgin coconut oil in lowering lipid levels in serum and tissues and LDL oxidation by physiological oxidants. This property of VCO may be attributed to the biologically active polyphenol components present in the oil
Matti Narkia

Berberine is a novel cholesterol-lowering drug working through a unique mechanism disti... - 0 views

    Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins.
    Kong W, Wei J, Abidi P, Lin M, Inaba S, Li C, Wang Y, Wang Z, Si S, Pan H, Wang S, Wu J, Wang Y, Li Z, Liu J, Jiang JD.
    Nat Med. 2004 Dec;10(12):1344-51. Epub 2004 Nov 7.
    PMID: 15531889

    We identify berberine (BBR), a compound isolated from a Chinese herb, as a new cholesterol-lowering drug. Oral administration of BBR in 32 hypercholesterolemic patients for 3 months reduced serum cholesterol by 29%, triglycerides by 35% and LDL-cholesterol by 25%. Treatment of hyperlipidemic hamsters with BBR reduced serum cholesterol by 40% and LDL-cholesterol by 42%, with a 3.5-fold increase in hepatic LDLR mRNA and a 2.6-fold increase in hepatic LDLR protein. Using human hepatoma cells, we show that BBR upregulates LDLR expression independent of sterol regulatory element binding proteins, but dependent on ERK activation. BBR elevates LDLR expression through a post-transcriptional mechanism that stabilizes the mRNA. Using a heterologous system with luciferase as a reporter, we further identify the 5' proximal section of the LDLR mRNA 3' untranslated region responsible for the regulatory effect of BBR. These findings show BBR as a new hypolipidemic drug with a mechanism of action different from that of statin drugs.
Matti Narkia

Treatment of Type 2 Diabetes and Dyslipidemia with the Natural Plant Alkaloid Berberine... - 0 views

    Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine.
    Zhang Y, Li X, Zou D, Liu W, Yang J, Zhu N, Huo L, Wang M, Hong J, Wu P, Ren G, Ning G.
    J Clin Endocrinol Metab. 2008 Jul;93(7):2559-65. Epub 2008 Apr 8.
    PMID: 18397984

    Conclusions: Berberine is effective and safe in the treatment of type 2 diabetes and dyslipidemia.
Matti Narkia

Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on bloo... - 0 views

    Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans.
    Tricon S, Burdge GC, Kew S, Banerjee T, Russell JJ, Jones EL, Grimble RF, Williams CM, Yaqoob P, Calder PC.
    Am J Clin Nutr. 2004 Sep;80(3):614-20.
    PMID: 15321800

    Conclusion: Divergent effects of cis-9,trans-11 CLA and trans-10,cis-12 CLA appear on the blood lipid profile in healthy humans: trans-10,cis-12 CLA increases LDL:HDL cholesterol and total:HDL cholesterol, whereas cis-9,trans-11 CLA decreases them.
Matti Narkia

Effects of dairy products naturally enriched with cis-9,trans-11 conjugated linoleic ac... - 0 views

    Effects of dairy products naturally enriched with cis-9,trans-11 conjugated linoleic acid on the blood lipid profile in healthy middle-aged men.
    Tricon S, Burdge GC, Jones EL, Russell JJ, El-Khazen S, Moretti E, Hall WL, Gerry AB, Leake DS, Grimble RF, Williams CM, Calder PC, Yaqoob P.
    Am J Clin Nutr. 2006 Apr;83(4):744-53.
    PMID: 16600923

    CONCLUSION: Dairy products naturally enriched with cis-9,trans-11 CLA and trans-11 18:1 do not appear to have a significant effect on the blood lipid profile
Matti Narkia

n-3 Fatty acids and cardiovascular disease evidence explained and mechanisms explored. ... - 0 views

    n-3 Fatty acids and cardiovascular disease: evidence explained and mechanisms explored.
    Calder PC.
    Clin Sci (Lond). 2004 Jul;107(1):1-11. Review.
    PMID: 15132735


    It is clear from the forgoing discussion that long-chain n-3 fatty acids have been proven to be effective in secondary prevention of MI, with a particularly marked effect on sudden death. Thus it would be prudent to advise post-MI patients to increase long-chain n-3 PUFA consumption. Epidemiological studies, studies investigating effects on classic and emerging risk factors and mechanistic studies indicate that long-chain n-3 fatty acids also play a key role in primary prevention. This is supported by studies in animal models, including monkeys. Thus long-chain n-3 fatty acid consumption should be promoted for all individuals especially those at risk of developing cardiovascular disease. This is the reason why a number of organizations have now made recommendations relating to the intake of fatty fish (for example [3]) and of long-chain n-3 PUFAs (Table 6). It is clear that there is a wide gap between current intakes of long-chain n-3 PUFAs and many of these recommendations (Table 6). To meet these recommendations strategies other than increased consumption of fatty fish may be required.
Matti Narkia

The Heart Scan Blog: Beating the Heart Association diet is child's play - 0 views

    In response to the Heart Scan Blog post, Post-Traumatic Grain Disorder, Anne commented:

    While on the American Heart Association diet my lipids peaked in 2003. I even tried the Ornish diet for a short time, but found it impossible.

    Total Cholesterol: 201
    Triglycerides: 263
    HDL: 62
    LDL: 86

    After I stopped eating gluten (I am very sensitive), my lipid panel improved slightly. This past year I started eating to keep my blood sugar under control by eliminating sugars and other grains. Now this is my most recent lab:

    Total Cholesterol: 162
    Triglycerides: 80
    HDL: 71
    LDL: 75
Matti Narkia

An Isoenergetic Very Low Carbohydrate Diet Improves Serum HDL Cholesterol and Triacylgl... - 0 views

    An isoenergetic very low carbohydrate diet improves serum HDL cholesterol and triacylglycerol concentrations, the total cholesterol to HDL cholesterol ratio and postprandial pipemic responses compared with a low fat diet in normal weight, normolipidemic women.
    Volek JS, Sharman MJ, Gómez AL, Scheett TP, Kraemer WJ.
    J Nutr. 2003 Sep;133(9):2756-61.
    PMID: 12949361
Matti Narkia

Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipid... - 0 views

    Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia -- Krauss et al. 83 (5): 1025 -- American Journal of Clinical Nutrition
    Changes in peak LDL diameter (Table 2) and mass concentrations of LDL subfractions (Table 3) induced by each of the diets were reflected by changes in the proportions of subjects exhibiting LDL subclass pattern B (Figure 2). There were linear reductions in the prevalence of pattern B as a function of reduced carbohydrate intake after both the stable-weight and weight-loss periods. However, the slopes of these relations differed (P = 0.04) such that the magnitude of the reduction in expression of pattern B induced by weight loss increased in association with the percentage of carbohydrate intake.

    Conclusions: Moderate carbohydrate restriction and weight loss provide equivalent but nonadditive approaches to improving atherogenic dyslipidemia. Moreover, beneficial lipid changes resulting from a reduced carbohydrate intake were not significant after weight loss.

    Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia.
    Krauss RM, Blanche PJ, Rawlings RS, Fernstrom HS, Williams PT.
    Am J Clin Nutr. 2006 May;83(5):1025-31; quiz 1205. Erratum in: Am J Clin Nutr. 2006 Sep;84(3):668.
    PMID: 16685042
Matti Narkia

Modification of Lipoproteins by Very Low-Carbohydrate Diets -- Volek et al. 135 (6): 13... - 0 views

    Modification of lipoproteins by very low-carbohydrate diets.
    Volek JS, Sharman MJ, Forsythe CE.
    J Nutr. 2005 Jun;135(6):1339-42. Review.
    PMID: 15930434
Matti Narkia

A Ketogenic Diet Favorably Affects Serum Biomarkers for Cardiovascular Disease in Norma... - 0 views

    The results suggest that a short-term ketogenic diet does not have a deleterious effect on CVD risk profile and may improve the lipid disorders characteristic of atherogenic dyslipidemia.

    A ketogenic diet favorably affects serum biomarkers for cardiovascular disease in normal-weight men.
    Sharman MJ, Kraemer WJ, Love DM, Avery NG, Gómez AL, Scheett TP, Volek JS.
    J Nutr. 2002 Jul;132(7):1879-85.
    PMID: 12097663
Matti Narkia

A Low-Carbohydrate, Ketogenic Diet versus a Low-Fat Diet To Treat Obesity and Hyperlipi... - 0 views

    Conclusions: Compared with a low-fat diet, a low-carbohydrate diet program had better participant retention and greater weight loss. During active weight loss, serum triglyceride levels decreased more and high-density lipoprotein cholesterol level increased more with the low-carbohydrate diet than with the low-fat diet.

    A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia: a randomized, controlled trial.
    Yancy WS Jr, Olsen MK, Guyton JR, Bakst RP, Westman EC.
    Ann Intern Med. 2004 May 18;140(10):769-77.
    PMID: 15148063
Matti Narkia

Low-carbohydrate diets increase LDL: debunking the myth | The Blog of Michael R. Eades... - 0 views

    This week sees the publication of yet another study showing the superiority of the low-carbohydrate diet as compared to the low-fat diet. This study, published in the prestigious American Journal of Clinical Nutrition, demonstrates that subjects following the low-carb diet experience a decrease in triglyceride levels and an increase in HDL-cholesterol (HDL) levels; and that these changes are accompanied by a minor increase in LDL-cholesterol (LDL), which prompts the authors to issue a caveat.

    Yes, although just about all the parameters that lipophobes worry about improved with the low-carb diet, the small increase in LDL has caused great concern and has prompted the authors to gravely announce that this small increase is troublesome and should be monitored closely in anyone who may be at risk for heart disease. Since most people who go on low-carb diets do so to deal with obesity issues, and since obesity is a risk factor for heart disease, it would appear that this small increase in LDL often seen in those following a low-carb diet could put these dieters at risk. Does it? We'll see.
Matti Narkia

Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocalor... - 0 views

    Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 mo.
    Brinkworth GD, Noakes M, Buckley JD, Keogh JB, Clifton PM.
    Am J Clin Nutr. 2009 May 13. [Epub ahead of print]
    PMID: 19439458
Matti Narkia

What can we expect from omega-3 fatty acids? - Cleveland Clinic Journal of Medicine - 0 views

    What can we expect from omega-3 fatty acids?
    Chan EJ, Cho L.
    Cleve Clin J Med. 2009 Apr;76(4):245-51.
    PMID: 19339640
    doi: 10.3949/ccjm.76a.08042
Matti Narkia

Alternative Treatment Discovered for Lowering Triglycerides - 0 views

    Studies done with laboratory rats suggest that supplementation of their diet with lipoic acid had a significant effect in lowering triglycerides.
Matti Narkia

Consumption of one egg per day increases serum lutein and zeaxanthin concentrations in ... - 0 views

    Consumption of one egg per day increases serum lutein and zeaxanthin concentrations in older adults without altering serum lipid and lipoprotein cholesterol concentrations.
    Goodrow EF, Wilson TA, Houde SC, Vishwanathan R, Scollin PA, Handelman G, Nicolosi RJ.
    J Nutr. 2006 Oct;136(10):2519-24.
    PMID: 16988120

    These findings indicate that in older adults, 5 wk of consuming 1 egg/d significantly increases serum lutein and zeaxanthin concentrations without elevating serum lipids and lipoprotein cholesterol concentrations.
1 - 20 of 31 Next ›
Showing 20 items per page